Florian Fischer
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Florian Fischer
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
25
| Public Company | Biotechnology | 25 |
Vivendy Therapeutics Ltd.
 Vivendy Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Vivendy Therapeutics Ltd. develops enzyme replacement therapy and biological products. It has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity-enhancing the efficacy of the therapy in MPS IVA significantl. The company was founded in March 2006 and is headquartered in Basel, Switzerland.
10
| Extinct | Hospital/Nursing Management | 10 |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany.
2
| Subsidiary | Medical Specialties | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Florian Fischer tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ADMA BIOLOGICS, INC. | Biotechnology | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Public Communications Contact | |
| BIOTEST AG | Pharmaceuticals: Other | Chairman | |
| PRESCIENT THERAPEUTICS LIMITED | Biotechnology | Director/Board Member | |
Carl Zeiss Jena GmbH
 Carl Zeiss Jena GmbH Medical SpecialtiesHealth Technology Carl Zeiss Jena GmbH engages in the design, prototyping, batch production, and testing of optical systems, single components, and auxiliary materials. It also provides services such as calibration, sampling of injection-molded and machined parts, hardness testing, heat treatment of materials, electromagnetic compatibility testing, and environmental simulation. The company is headquartered in Jena, Germany. | Medical Specialties | Corporate Officer/Principal | |
| University of Freiburg | College/University | Doctorate Degree Doctorate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree Graduate Degree | |
| ATON | Pharmaceuticals: Major | Director/Board Member | |
| Brandeis University | College/University | Doctorate Degree Doctorate Degree | |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Technische Universität München | College/University | Doctorate Degree Doctorate Degree | |
Inotech Biotechnologies AG
 Inotech Biotechnologies AG Pharmaceuticals: MajorHealth Technology Inotech Biotechnologies AG specializes in research, development and production of biopharmaceuticals products. It helps people by creating apps and gadgets to reach their health and fitness goals. The company is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman | |
IDEA AG
 IDEA AG Pharmaceuticals: MajorHealth Technology IDEA AG develops pain therapeutics and biopharmaceutical drugs. The firm develops and commercializes non-invasive therapeutic drugs and the targeted pain therapeutics for arthritic and osteoporosis-related inflammation, chronic pain and diseases. Its technology platform is based on proprietary carriers applied on skin and engineered to diminish side effects and increase drug potency. The company founded by Gregor Cevc in 1993 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Universität Stuttgart | College/University | Doctorate Degree Doctorate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Undergraduate Degree | |
| University of Leiden | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Giessen | College/University | Doctorate Degree | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Technische Universität Braunschweig | College/University | Undergraduate Degree Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman | |
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Hospital/Nursing Management | Corporate Officer/Principal | |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Medical Specialties | Director/Board Member Director/Board Member Chairman | |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Founder Director/Board Member | |
| Pulmopharm GmbH | Corporate Officer/Principal | ||
Pacific Channel Ltd.
 Pacific Channel Ltd. Investment ManagersFinance Pacific Channel Ltd (Pacific Channel) is a venture capital firm founded in 2006 by Brent S. Ogilvie. The firm is headquartered in Auckland, New Zealand. | Investment Managers | Private Equity Investor | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member | |
Centogene AG
 Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
| Akalpa LifeScience Consulting Ltd. | Director/Board Member | ||
Footfalls & Heartbeats (UK) Ltd.
 Footfalls & Heartbeats (UK) Ltd. TextilesProcess Industries Footfalls & Heartbeats (UK) Ltd. designs, develops, and manufactures smart textiles. The firm uses nano-scale interactions within the textile to make the fabric itself the sensor, avoiding the need for wires or miniature electronics. The company was founded by Simon McMaster in 2010 and is headquartered in Nottingham, the United Kingdom. | Textiles | Chief Executive Officer | |
| Affimed AG | Chairman Director/Board Member | ||
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member Director/Board Member | |
| Jenowis AG | Chief Executive Officer | ||
Upstream Medical Technologies Ltd.
 Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | Biotechnology | Director/Board Member | |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| CENTOGENE N.V. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Chief Operating Officer | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany. | Biotechnology | Chief Executive Officer | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Germania | 27 |
| Stati Uniti | 8 |
| Svizzera | 8 |
| Nuova-Zelanda | 4 |
| Regno Unito | 3 |
Settori
| Health Technology | 23 |
| Consumer Services | 13 |
| Commercial Services | 7 |
| Health Services | 3 |
| Finance | 2 |
Posizioni
| Director/Board Member | 151 |
| Corporate Officer/Principal | 75 |
| Chairman | 37 |
| Chief Tech/Sci/R&D Officer | 36 |
| Chief Executive Officer | 35 |
Contatti più connessi
| Insiders | |
|---|---|
| Jörg Neermann | 34 |
| Gerhard Ries | 27 |
| Ferdinand Verdonck | 25 |
| Thomas O. Hecht | 24 |
| Berndt A. E. Modig | 23 |
| Mathieu Simon | 22 |
| Bernhard R. M. Ehmer | 16 |
| Frank Mühlenbeck | 16 |
| Gosse Bote Bruinsma | 16 |
| Caroline Y. Stewart | 16 |
| Domenico Valerio | 15 |
| Miroslav S. Ravic | 15 |
| Ulrich Grau | 12 |
| John Stuart Patton | 12 |
| Arndt Rolfs | 11 |
- Borsa valori
- Insiders
- Florian Fischer
- Connessioni Società
